KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Deferred Taxes (2018 - 2025)

Historic Deferred Taxes for BioNTech SE (BNTX) over the last 2 years, with Q4 2019 value amounting to $6.5 million.

  • BioNTech SE's Deferred Taxes rose 14211.11% to $6.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was $6.5 million, marking a year-over-year increase of 14211.11%. This contributed to the annual value of $6.6 million for FY2019, which is 13668.26% up from last year.
  • According to the latest figures from Q4 2019, BioNTech SE's Deferred Taxes is $6.5 million, which was up 14211.11% from $8.8 million recorded in Q3 2019.
  • In the past 5 years, BioNTech SE's Deferred Taxes registered a high of $8.8 million during Q3 2019, and its lowest value of $2.7 million during Q4 2018.